Swiss Pharmaceuticals Gigatropin

Description

Swiss Pharmaceuticals GIGATROPIN

Swiss Pharmaceuticals GIGATROPIN is a specialist multi-compound capsule product containing a combination of androgen receptor modulators, ibutamoren, Epistane and Arimistane.

Each original container provides 50 capsules. According to the product label, one capsule contains a combined declared specification of 84 mg. The formula includes 40 mg of Arimistane, 10 mg of Epistane, 5 mg of RAD-140, 10 mg of LGD-4033, 15 mg of MK-677 and 4 mg of YK-11. Gelatin and magnesium stearate are listed as additional ingredients.

Multi-compound formula

GIGATROPIN combines six individually declared compounds in a single capsule format:

• Arimistane – 40 mg
• Epistane – 10 mg
• RAD-140 – 5 mg
• LGD-4033 – 10 mg
• MK-677 – 15 mg
• YK-11 – 4 mg
• Total declared specification – 84 mg
• Package size – 50 capsules

RAD-140 and LGD-4033 are commonly classified as selective androgen receptor modulators. YK-11 is also grouped with androgen receptor modulators in anti-doping and analytical literature. MK-677, also known as ibutamoren, is not technically a SARM; it is an orally administered growth-hormone secretagogue receptor agonist.

Clear product identification

The original packaging features distinctive gold Swiss Pharmaceuticals branding and identifies GIGATROPIN as an “HGH & Testosterone Activator.” This wording is part of the manufacturer’s label presentation and should not be interpreted as proof of approved therapeutic effects.

A professional product listing should allow customers to verify:

• the Swiss Pharmaceuticals brand,
• the GIGATROPIN product name,
• the 50-capsule package size,
• the complete ingredient panel,
• the amount of each declared compound,
• the batch and expiry information,
• the authenticity code,
• the condition of the original safety seal.

The physical bottle should remain the primary source for the final composition and warning information. Do not distribute a product when the seal is damaged, the label appears altered or the declared specifications differ from the online listing.

Important safety and regulatory information

GIGATROPIN should not be described as a conventional vitamin, ordinary sports supplement or approved medicinal treatment. The included compounds are experimental or steroid-related substances, and claims promising guaranteed muscle growth, fat reduction, hormonal enhancement, increased strength or faster recovery should be avoided.

The FDA considers products marketed with compounds such as LGD-4033, RAD-140 and YK-11 to be unapproved drugs in the United States and warns that SARM products may be associated with serious health risks, including liver injury and cardiovascular complications.

Information for tested athletes

RAD-140, LGD-4033 and YK-11 are included among prohibited selective androgen receptor modulators on the 2026 World Anti-Doping Agency Prohibited List. Ibutamoren is also prohibited as a growth-hormone secretagogue. Athletes subject to anti-doping controls should treat the entire formula as prohibited in sport.

This description is provided exclusively for accurate catalogue identification. It does not provide medical advice, instructions for use, cycle guidance or a guarantee of physical or performance-related results.